Catalyst Wire Dossier Catalyst Wire Dossier

Fludarabine/Busulfan and Cyclophosphamide conditioning

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fludarabine/Busulfan and Cyclophosphamide conditioning, covering 2018-11-02 to 2018-11-02. Get the full timeline:

Most recent: Clinical Trial Update: Fludarabine/Busulfan and Cyclophosphamide Conditioning for Adult Lymphoid Malignancies [Phase 2]

See pricing